Bioanalysis
Bioanalysis is a peer-reviewed scientific journal covering analytical methods used in biomedical and pharmaceutical research.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Bioanalysis is an international, peer-reviewed scientific journal established in 2009 and published by Taylor & Francis. It focuses on the development, validation, application, and interpretation of analytical methods used to study biological samples, drugs, metabolites, biomarkers, and related molecular systems. Its subject area sits at the intersection of analytical chemistry, pharmaceutical development, bioanalytical method validation, clinical research, and life-science measurement. The journal addresses a broad range of bioanalytical practice. Topics include assays for drugs and metabolites, chromatography and other separation sciences, ligand-binding assays, metabolomics, and major detection technologies. This scope makes the publication relevant to researchers working in pharmaceutical and biopharmaceutical development, clinical and preclinical testing, toxicology, pharmacokinetics, biomarker research, and laboratory quality systems. The journal’s coverage extends beyond individual techniques to methodological performance, analytical robustness, validation, and the practical application of assays in research and development settings. Bioanalysis is published on a biweekly schedule. Its content is intended primarily for specialist readers, including academic scientists, pharmaceutical and biotechnology researchers, analytical chemists, laboratory scientists, regulatory and quality professionals, and other practitioners involved in the measurement of biological analytes. The journal is abstracted and indexed in major scientific and biomedical databases, including BIOSIS Previews, Chemical Abstracts, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. These services support the discovery and scholarly visibility of its research articles. The journal also maintains a professional community dimension through partnerships with Bioanalysis Zone, an online community focused on the field. Together they support two annual recognition programs: the Bioanalysis Young Investigator Award, presented since 2012, and the Bioanalysis Outstanding Contribution Award, presented since 2014. These awards connect the publication with professional development and recognition of researchers contributing to bioanalytical science. Neil Spooner of Spooner Bioanalytical Solutions Ltd in the United Kingdom is identified as the journal’s editor-in-chief. The publication remains an active specialist title within scientific and technical publishing. Reference material reports a 2025 impact factor of 2.1, although impact factors are time-specific bibliometric measurements rather than a permanent attribute of the journal.
History
Bioanalysis was established in 2009 as a specialist peer-reviewed journal devoted to the analytical study of biological materials and pharmaceutical compounds. Its creation reflected the growing importance of reliable measurement in drug discovery, development, clinical research, and biopharmaceutical science. Bioanalytical work commonly requires the quantification and characterization of drugs, metabolites, biomarkers, and other analytes in complex biological matrices, making method design and validation central to pharmaceutical and biomedical research. From its foundation, the journal’s scope has covered both established and developing analytical approaches. Its subject matter includes drug and metabolite assays, chromatography and separation science, ligand-binding assays, metabolomics, and important detection methods. This breadth allows the journal to address the full workflow of bioanalysis, from sample preparation and separation to detection, quantification, validation, and interpretation. The coverage is relevant to academic laboratories as well as pharmaceutical, biotechnology, contract research, and clinical research organizations. Bioanalysis is published by Taylor & Francis and appears on a biweekly schedule. Over time it has been incorporated into the information infrastructure used by researchers through abstracting and indexing in BIOSIS Previews, Chemical Abstracts, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. Inclusion in these databases increases the discoverability of the journal’s articles across chemistry, biomedical science, pharmacology, and life-science research communities. The publication has also developed links with the wider professional bioanalysis community. Through a partnership with Bioanalysis Zone, it supports the Bioanalysis Young Investigator Award, which has been presented since 2012, and the Bioanalysis Outstanding Contribution Award, which has been presented since 2014. These programs extend the journal’s role beyond article publication by highlighting early-career researchers and researchers whose work has made an important contribution to bioanalytical science. Neil Spooner, associated with Spooner Bioanalytical Solutions Ltd in the United Kingdom, is identified as editor-in-chief. Under its ongoing editorial and publishing operation, the journal continues to serve a specialist international readership concerned with analytical rigor, reproducibility, and the application of measurement science to pharmaceutical and biomedical questions. Reference material reports a 2025 impact factor of 2.1. Because bibliometric indicators vary by reporting year and methodology, that figure should be understood as a time-specific measure rather than a fixed description of the journal.
- 2025
Reported impact factor
[1]Reference material reports a 2025 impact factor of 2.1 for the journal.
- 2014
Outstanding Contribution Award introduced
[1]The Bioanalysis Outstanding Contribution Award began honoring significant contributions to the field.
- 2012
Young Investigator Award introduced
[1]The Bioanalysis Young Investigator Award began to recognize emerging contributors to bioanalytical science.
- 2009
Journal established
[1]Bioanalysis was established as a peer-reviewed scientific journal focused on bioanalytical methods and applications.
Products and positioning
A specialist scientific journal positioned at the intersection of bioanalytical science, analytical chemistry, pharmaceutical research, and biomedical measurement.
Peer-reviewed scientific journal · 2009
Bioanalysis
The journal publishes specialist research and scholarly material concerning bioanalytical science. Its coverage includes assays for drugs and metabolites, chromatography and separation sciences, ligand-binding assays, metabolomics, and key detection methods. The content serves researchers studying analytical performance, biological measurement, pharmaceutical development, biomarkers, and related biomedical applications.
Recent events
- 2025
Bioanalysis reports a 2025 impact factor of 2.1[1]
Other
Reference material reports that the journal had a 2025 impact factor of 2.1.
Bioanalysis continues its annual recognition programs[1]
Other
The journal partners with Bioanalysis Zone on the Bioanalysis Young Investigator Award and the Bioanalysis Outstanding Contribution Award, recognizing emerging researchers and significant contributions to the field.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/bioanalysis · Editorial policy · How profiles are compiled